Trial Outcomes & Findings for Feasibility of Performing Peripheral Pulmonary Lesion Biopsy Using Robotic Bronchoscopy-Guided Cryoprobe (NCT NCT05399082)
NCT ID: NCT05399082
Last Updated: 2024-10-17
Results Overview
Number of tissue samples that are considered by the bronchoscopist as adequate for further pathological analysis
COMPLETED
NA
30 participants
Baseline
2024-10-17
Participant Flow
Participant milestones
| Measure |
Standard Forceps Biopsy First, Then Research Cryoprobe Biopsy
Subjects who received standard forceps biopsy either first or second during their biopsy of lung lesions.
Standard forceps biopsy first, then crossover to receive the research cryoprobe biopsy during the procedure.
Cryoprobe biopsy: A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue
Standard forceps biopsy: Biopsy forceps used to collect tissue
|
Research Cryoprobe Biopsy First, Then Standard Forceps Biopsy
Subjects who received the research cryoprobe biopsy first or second during their biopsy of lung lesions.
Research cryoprobe biopsy first, then crossover to receive the standard forceps biopsy during the procedure.
Cryoprobe biopsy: A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue
Standard forceps biopsy: Biopsy forceps used to collect tissue
|
|---|---|---|
|
First Intervention
STARTED
|
15
|
15
|
|
First Intervention
COMPLETED
|
15
|
15
|
|
First Intervention
NOT COMPLETED
|
0
|
0
|
|
Second Intervention
STARTED
|
15
|
15
|
|
Second Intervention
COMPLETED
|
15
|
15
|
|
Second Intervention
NOT COMPLETED
|
0
|
0
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Feasibility of Performing Peripheral Pulmonary Lesion Biopsy Using Robotic Bronchoscopy-Guided Cryoprobe
Baseline characteristics by cohort
| Measure |
Standard Forceps Biopsy First, Then Research Cryoprobe Biopsy
n=15 Participants
Subjects who received standard forceps biopsy either first or second during their biopsy of lung lesions.
Standard forceps biopsy first, then crossover to receive the research cryoprobe biopsy during the procedure.
Cryoprobe biopsy: A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue
Standard forceps biopsy: Biopsy forceps used to collect tissue
|
Research Cryoprobe Biopsy First, Then Standard Forceps Biopsy
n=15 Participants
Subjects who received the research cryoprobe biopsy first or second during their biopsy of lung lesions.
Research cryoprobe biopsy first, then crossover to receive the standard forceps biopsy during the procedure.
Cryoprobe biopsy: A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue
Standard forceps biopsy: Biopsy forceps used to collect tissue
|
Total
n=30 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
70.3 years
STANDARD_DEVIATION 9.23 • n=5 Participants
|
70.2 years
STANDARD_DEVIATION 7.11 • n=7 Participants
|
70.3 years
STANDARD_DEVIATION 8.4 • n=5 Participants
|
|
Sex: Female, Male
Female
|
8 Participants
n=5 Participants
|
4 Participants
n=7 Participants
|
12 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
7 Participants
n=5 Participants
|
11 Participants
n=7 Participants
|
18 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Hispanic or Latino
|
0 Participants
n=5 Participants
|
2 Participants
n=7 Participants
|
2 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Not Hispanic or Latino
|
15 Participants
n=5 Participants
|
13 Participants
n=7 Participants
|
28 Participants
n=5 Participants
|
|
Ethnicity (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
White
|
14 Participants
n=5 Participants
|
15 Participants
n=7 Participants
|
29 Participants
n=5 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
15 participants
n=5 Participants
|
15 participants
n=7 Participants
|
30 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: BaselineNumber of tissue samples that are considered by the bronchoscopist as adequate for further pathological analysis
Outcome measures
| Measure |
Standard Forceps Biopsy
n=30 Participants
Subjects who received standard forceps biopsy either first or second during their biopsy of lung lesions.
Standard forceps biopsy: Biopsy forceps used to collect tissue
|
Research Cryoprobe Biopsy
n=30 Participants
Subjects who received the research cryoprobe biopsy first or second during their biopsy of lung lesions.
Cryoprobe biopsy: A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue
|
|---|---|---|
|
Ability to Successfully Obtain Sample
|
123 tissue samples
|
130 tissue samples
|
SECONDARY outcome
Timeframe: Biopsy procedure, approximately 3 hoursTotal time of biopsy procedure from first insertion of probe into robotic sheath to removal of specimens.
Outcome measures
| Measure |
Standard Forceps Biopsy
n=30 Participants
Subjects who received standard forceps biopsy either first or second during their biopsy of lung lesions.
Standard forceps biopsy: Biopsy forceps used to collect tissue
|
Research Cryoprobe Biopsy
n=30 Participants
Subjects who received the research cryoprobe biopsy first or second during their biopsy of lung lesions.
Cryoprobe biopsy: A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue
|
|---|---|---|
|
Duration of Biopsy Procedure
|
41 minutes
Interval 30.0 to 53.0
|
41 minutes
Interval 21.0 to 54.0
|
SECONDARY outcome
Timeframe: Biopsy procedure, approximately 60 secondsPopulation: This outcome measure was only collected and analyzed for the Research cryoprobe biopsy arm
Total freezing time for cryoprobe biopsies, measured in seconds
Outcome measures
| Measure |
Standard Forceps Biopsy
Subjects who received standard forceps biopsy either first or second during their biopsy of lung lesions.
Standard forceps biopsy: Biopsy forceps used to collect tissue
|
Research Cryoprobe Biopsy
n=30 Participants
Subjects who received the research cryoprobe biopsy first or second during their biopsy of lung lesions.
Cryoprobe biopsy: A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue
|
|---|---|---|
|
Freezing Time for Cryoprobe Biopsies
|
—
|
4.54 seconds
Standard Deviation 0.91
|
SECONDARY outcome
Timeframe: Biopsy procedure, approximately 3 hoursOne attempt is defined as insertion of the biopsy probe into the robotic sheath, activation/employment of the biopsy mechanism at the target site and retrieval via the robotic sheath. A biopsy attempt is successful if a tissue sample that is considered by the bronchoscopist to be adequate for further pathological analysis can be retrieved.
Outcome measures
| Measure |
Standard Forceps Biopsy
n=30 Participants
Subjects who received standard forceps biopsy either first or second during their biopsy of lung lesions.
Standard forceps biopsy: Biopsy forceps used to collect tissue
|
Research Cryoprobe Biopsy
n=30 Participants
Subjects who received the research cryoprobe biopsy first or second during their biopsy of lung lesions.
Cryoprobe biopsy: A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue
|
|---|---|---|
|
Number of Successful Biopsy Attempts
|
123 successful attempts
|
130 successful attempts
|
SECONDARY outcome
Timeframe: Pathology review, approximately 1 dayPopulation: Data was not collected nor analyzed due to inadequate tissue size, volume, and quality, no data were collected for this Outcome Measure
Pathologic description ranging from insufficient to diagnostic material
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Pathology review, approximately 1 dayPopulation: Data was not collected nor analyzed due to inadequate tissue size, volume, and quality, no data were collected for this Outcome Measure
Defined as the ability of the pathologist to make a diagnostic statement based on the histological analysis of the obtained tissue samples. Graded 1-4 with 1 being insufficient tissue and 4 being diagnostic material.
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Pathology review, approximately 1 dayPopulation: Data was not collected nor analyzed due to inadequate tissue size, volume, and quality, no data were collected for this Outcome Measure
The total histological area of the biopsy samples. Measured in (mm\^2)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Pathology review, approximately 1 dayPopulation: Data was not collected nor analyzed due to inadequate tissue size, volume, and quality, no data were collected for this Outcome Measure
The total percent area of crush artifacts identified in the biopsy samples (percent total area)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Pathology review, approximately 1 dayPopulation: Data was not collected nor analyzed due to inadequate tissue size, volume, and quality, no data were collected for this Outcome Measure
The total percent area of other pathologic artifacts identified in the tissue biopsy samples that obscure pathological assessment (percent total area)
Outcome measures
Outcome data not reported
SECONDARY outcome
Timeframe: Pathology review, approximately 1 dayPopulation: Data was not collected nor analyzed due to inadequate tissue size, volume, and quality, no data were collected for this Outcome Measure
The total percent area of different tissue types identified in the tissue biopsy samples. Defined as the total of alveoli, bronchus, mucus, blood, and target tissue (percent total area)
Outcome measures
Outcome data not reported
Adverse Events
Standard Forceps Biopsy
Research Cryoprobe Biopsy
Serious adverse events
Adverse event data not reported
Other adverse events
| Measure |
Standard Forceps Biopsy
n=30 participants at risk
Subjects who received standard forceps biopsy either first or second during their biopsy of lung lesions.
Standard forceps biopsy: Biopsy forceps used to collect tissue
|
Research Cryoprobe Biopsy
n=30 participants at risk
Subjects who received the research cryoprobe biopsy first or second during their biopsy of lung lesions.
Cryoprobe biopsy: A 1.1mm disposable cryoprobe that is passed through the working channel of the Ion Robotic bronchoscope to collect biopsy tissue
|
|---|---|---|
|
Injury, poisoning and procedural complications
Minor bleeding
|
10.0%
3/30 • Number of events 3 • Adverse events were collected for each subject from baseline until completion of the standard of care post procedure follow-up for approximately 2 weeks
|
6.7%
2/30 • Number of events 3 • Adverse events were collected for each subject from baseline until completion of the standard of care post procedure follow-up for approximately 2 weeks
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place